Proof of Usefulness Report

Ovy

Analysis completed on 2/13/2026

+505
Proof of Usefulness Score
Industry Mainstay

Ovy is a high-utility Health-Tech project with verified Class IIb Medical Device certification (MDR) for contraception, distinguishing it significantly from standard wellness apps. External search confirms strong traction with >1M downloads and >500k hardware units sold, backed by strategic investor Beurer. However, the submission quality was notably poor ('most people have used my product'), resulting in a lower Response Quality score despite the project's intrinsic high value.

Ready to Compete for $150k+ in Prizes?

Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes

View All Reports

Score Breakdown

Real World Utility+142.5
Audience Reach Impact+90.0
Technical Innovation+102.0
Evidence Of Traction+108.0
Market Timing Relevance+90.0
Functional Completeness+15.0
Subtotal+547.5
Usefulness Multiplierx0.92
Final Score+505

Project Details

Project URL
Description
Die Ovy GmbH ist ein innovatives Health-Tech-Unternehmen mit Sitz in Hamburg, gegründet von den Schwestern Eva Leonhardt und Lina Wüller. Mit der Vision, die Frauengesundheit durch digitale Lösungen nachhaltig zu verbessern, hat das Unternehmen eine Abo-basierte Verhütungs- und Kinderwunsch-App entwickelt, die in Kombination mit einem Bluetooth-fähigen Basalthermometer von Frauen* und Paaren genutzt wird. Die Ovy App unterstützt dabei, die fruchtbaren Tage im Zyklus präzise zu bestimmen und liefert fundierte Einblicke in die reproduktive Gesundheit. Zum Produktportfolio gehören neben weiteren Apps eine eigene Bluetooth-Hardware und Teststreifen. Zu den Investoren zählen der Medizinproduktehersteller Beurer sowie der Verlag Klambt. Die Ovy App ist offiziell als Verhütungsmittel und Kinderwunsch-App nach der MDR (Medical Device Regulation) in der Klasse IIb zugelassen. Unsere Vision? Die Zukunft der Frauengesundheit aktiv mitgestalten – sicher, natürlich und wissenschaftlich fundiert. ▫️▫️▫️▫️▫️▫️▫️ Ovy GmbH is an innovative health-tech company based in Hamburg, founded by sisters Eva Leonhardt and Lina Wüller. With a vision to sustainably improve women’s health through digital solutions, the company has developed a subscription-based contraception and fertility app. Used in combination with a Bluetooth-enabled basal thermometer, the Ovy App helps women and couples precisely identify fertile days and provide valuable insights into reproductive health. The product portfolio also includes additional apps, proprietary Bluetooth hardware, and test strips. Investors include the medical device manufacturer Beurer and the publishing house Klambt. The Ovy App is officially certified as a contraceptive and fertility app under the MDR (Medical Device Regulation), classified as a Class IIb medical device. We are here to actively shape the future of female health – safe, natural, and scientifically grounded.

Algorithm Insights

Market Position
Strong market validation with clear user adoption patterns
User Engagement
Documented reach suggests active user community
Technical Stack
Modern tech stack aligned with sponsor technologies

Recommendations to Increase Usefulness Score

Document User Growth

Provide specific metrics on user acquisition and retention rates

Showcase Revenue Model

Detail sustainable monetization strategy and current revenue streams

Expand Evidence Base

Include testimonials, case studies, and third-party validation

Technical Roadmap

Share development milestones and feature completion timeline